Gastroesophageal Reflux Disease Treatment Devices Market Growth Accelerated By Rising Prevalence Of GERD
Gastroesophageal Reflux Disease Treatment Devices Market
Gastroesophageal
reflux disease (GERD) affects millions of people worldwide and causes symptoms
like heartburn and acid regurgitation. GERD treatment devices help provide
relief from these symptoms by reducing stomach acid reflux into the esophagus.
Devices like endoscopic fundoplication systems are minimally invasive and
provide relief comparable to traditional surgeries.
The
global Gastroesophageal Reflux Disease
Treatment Devices Market is estimated to be valued at US$ 3.2 Billion in 2023 and is expected to exhibit a CAGR Of 11% over the forecast period 2023-2030,
as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rising prevalence of GERD worldwide is expected to drive growth of the GERD
treatment devices market over the forecast period. According to the National
Institute of Diabetes and Digestive and Kidney Diseases, GERD affects as many
as one in five adults in North America at least once a month. Lifestyle changes
and an increasingly Westernized diet have contributed to rising obesity rates -
a major risk factor for GERD. Growing awareness regarding the safety and
efficacy of minimally invasive treatment devices compared to lifelong
medication dependence is also prompting more patients and healthcare providers
to consider surgical treatments like endoscopic fundoplication. This is
expected to boost the demand for GERD treatment devices in the coming years.
Segment
Analysis
The global Gastroesophageal Reflux Disease Treatment Devices Market is
segmented based on product type and end user. Under product type, the
dominating segment is bravo capsule pH monitoring which holds the largest
market share of over 35%. Bravo capsule pH monitoring helps in accurate diagnosis
of acid reflux by providing 48-hour continuous pH monitoring. This helps
physicians to effectively diagnose and treat acid reflux conditions in
patients.
Key Takeaways
The Global Gastroesophageal Reflux Disease Treatment
Devices Market Demand is
expected to witness high growth.
Regional
analysis: North American region currently dominates the market and is expected
to maintain its dominance during the forecast period. Factors such as the
growing prevalence of GERD among adults, availability of advanced diagnostic
and treatment procedures, and favorable reimbursement policies drive the market
growth in this region.
Key players operating in the Gastroesophageal Reflux Disease Treatment Devices
market are Medtronic, Johnson & Johnson, TORAX Medical, MediGus,
EndoGastric Solutions. Medtronic is one of the leading players offering
technologically advanced and minimally invasive procedures for GERD treatment.
The company offers LINX Reflux Management system which is a small flexible band
of interlocking beads tailored to fit around the lower esophageal sphincter to
prevent acid reflux.
Get more insights on this topic :
Comments
Post a Comment